Narrative Strategy: Category Creation
A name doesn't make a category. A narrative does.
Category creation gets treated like a marketing move. Pick a clever name, run a launch campaign, hope it sticks. That’s not what’s happening when a category actually takes hold. What’s happening is world-building. Someone is deciding what’s real before the market has agreed on it, and then giving everyone else the words to agree with.
A category doesn’t exist because a company decides to call something new. It exists because enough people start using the same language to describe the same reality. That’s the part marketing can’t do on its own. A press release can introduce a term. It can’t make a hundred different stakeholders, investors, regulators, customers, competitors, all reach for that term independently, unprompted, because it’s the only word that fits what they’re seeing. That’s a narrative achievement, not a copywriting one.
Here’s why the distinction matters. Every market has a moment where the existing words stop being accurate. A shift happens inside a company or an industry, and the old vocabulary keeps getting used anyway, because nobody’s replaced it yet. That gap, between what’s actually true and what people still call it, is where category creation lives. Whoever names the gap first doesn’t just get credit for being clever. They set the terms everyone else has to think inside of. Miss that window and you inherit somebody else’s language instead, usually a competitor’s, sometimes an analyst’s, and you spend years arguing inside a frame you didn’t build.
I’m watching this happen right now in personalized medicine. A platform gets built to do one thing at population scale, a vaccine, a screening test, a standard protocol, priced and distributed the way mass-market products are priced and distributed. Then the same underlying technology gets pointed at a single patient. One tumor’s specific mutations. One immune profile. A treatment designed for an audience of one, built on a platform that was never described that way. The company hasn’t changed what it’s capable of. It’s changed what it’s for, and the vocabulary hasn’t caught up. Investors still describe it by its original product category. Clinicians reach for “personalized” as a marketing adjective instead of a structural fact. Nobody has said, plainly, that this is a different kind of company doing two fundamentally different kinds of work on the same foundation. Until someone does, the category stays borrowed, held together by “platform” and “pipeline,” neither of which actually explains what’s true.
That’s the example. It’s not the point. The point is what makes a category real in the first place, and that’s narrative strategy, not positioning.
A name alone doesn’t hold. It needs a narrative that recognizes the past, the present, and the future. A system of stories that makes the new category irresistible.
The past has to explain what the old category couldn’t account for. Not why it was bad, just why it was insufficient. In personalized medicine, the old category was “treatment.” One drug, one indication, one dose, tested for the average patient and prescribed to everyone who fit the label. That framing worked when medicine had no way to act on what made one patient different from the next.
The present has to show the evidence the new reality already exists. Not a prediction, proof. A platform originally built for scale is now generating something that starts over with every single patient, and it’s happening now, not someday. That’s visible in the pipeline itself, if anyone bothers to describe it accurately instead of defaulting to the language the platform launched with.
The future has to explain the stakes of not naming it. If a company doing genuinely different work under one roof, mass-market and n-of-one, keeps getting described by its oldest, simplest product, it gets evaluated like that product. Priced like it. Trusted or doubted like it. The more interesting and more difficult thing the company is actually building stays invisible, not because it isn’t real, but because nobody gave the market a word for it.
Skip any one of the three and the category doesn’t take. A name with no past feels invented. A name with no present feels speculative. A name with no future feels academic, interesting but not urgent enough to act on.
This is the actual mechanism, and it’s why narrative strategy is essential to category creation rather than a nice complement to it. Marketing sells into a frame that already exists. It optimizes language for a category everyone already agrees on. Category creation has no frame to sell into yet. The only tool that builds one is the same tool that’s always built shared reality: a narrative, grounded in what came before, proven by what’s true now, and made urgent by what’s at stake next. That’s not a metaphor for narrative strategy. That’s the actual job.
The platform-built-for-scale-now-serving-one-patient problem is one place this is happening right now. It is not the only place. Any company sitting on a real shift, in what it does, what it sells, what it actually is, and still being described with the old words, is a category creation opportunity waiting for someone to do the naming.
I'm Ari Mostov. I help biotech and life science leaders close the gap between what their company has become and the words the market is still using to describe it. If your company is living this gap right now, let's talk.